Tumor-derived antioxidants suppress immunity by depriving T cells of reactive oxygen species
Science · 2026
DOI: 10.1126/science.adz8203 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science, 2026. Verfasst von Alexander J Wesolowski und 31 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, University of Cambridge, Cambridge, UK. Hauptthemen laut MEDLINE: Antioxidants, Neoplasms, Peroxiredoxins, Reactive Oxygen Species. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 63 Literaturangaben. Gefördert von: Wellcome, European Research Council, UK Medical Research Council.
Abstract (Originalsprache)
Reactive oxygen species (ROS) promote genomic instability and fuel oncogenic signaling in cancer, but antioxidant therapies have so far failed to improve, or worsen, cancer outcomes. Emerging data suggest that T cells depend on ROS for signal transduction. In this study, we show that tumors exploit this dependency, releasing antioxidant enzymes into the tumor environment to suppress T cell–mediated antitumor immunity. The interstitial fluid of tumors possesses potent antioxidant activity, associated with enrichment of the antioxidant enzyme peroxiredoxin 1 (PRDX1). Extracellular PRDX1 deprives T cells of ROS, preventing oxidative inactivation of phosphatases required for T cell receptor–driven kinase signaling and effector function. Prdx1 is up-regulated upon cancer immunoediting, and loss of PRDX1 within tumors enhances antitumor immunity and immunotherapy responses. These findings define a redox-dependent mechanism of tumor immunosuppression that is potentially amenable to therapeutic intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pathology, University of Cambridge, Cambridge, UK.
- CRUK Cambridge Centre, Cambridge, UK.
- Babraham Institute, Babraham, Cambridgeshire, UK.
- Centre de Recherche en Cancérologie de Marseille, Marseille, France.
- Department of Surgery, Oregon Health and Science University, Portland, OR, USA.
- MRC Mitochondrial Biology Unit, University of Cambridge, Cambridge, UK.
ORCID-Profile: Alexander J Wesolowski, Ardon M Pillay, Panagiota Vardaka, Iliana Loffreda, Chelsea Jenkin, Andrew M James, Teresa von Linde, Alberto G Conti, Sheue-Fen Tzeng, Layla Dahmani, Alexander C Evans, Sarah K Whiteside, Yumi Yamashita-Kanemaru, Charlotte J Imianowski, Jie Yang, Ignacio Moraga Gonzalez, Jack Chapman, Klaus Okkenhaug, Michael P Murphy, Bartlomiej Swiatczak, Geoffrey Guittard, Enrico Lugli, Lukas Flatz, Ping-Chih Ho, Robert L Eil, Rahul Roychoudhuri
Förderung
- Wellcome
- European Research Council
- UK Medical Research Council
- Ricerca sul Cancro
Zitieren
APA
Wesolowski, A. J., Pillay, A. M., Vardaka, P., Nasrallah, R., Greaves, R., Li, H., Loffreda, I., Jenkin, C., James, A. M., Nübling, A., Ward, C. J., von Linde, T., Conti, A. G., Tzeng, S. F., Dahmani, L., Evans, A. C., Whiteside, S. K., Yamashita-Kanemaru, Y., Imianowski, C. J., …, & Roychoudhuri, R. (2026). Tumor-derived antioxidants suppress immunity by depriving T cells of reactive oxygen species. Science. https://doi.org/10.1126/science.adz8203
Vancouver
Wesolowski AJ, Pillay AM, Vardaka P, Nasrallah R, Greaves R, Li H, et al. Tumor-derived antioxidants suppress immunity by depriving T cells of reactive oxygen species. Science. 2026. doi:10.1126/science.adz8203
BibTeX
@article{Wesolowski2026,
author = {Wesolowski, Alexander J and Pillay, Ardon M and Vardaka, Panagiota and Nasrallah, Rabab and Greaves, Randy and Li, Housaiyin and Loffreda, Iliana and Jenkin, Chelsea and James, Andrew M and Nübling, Alica and Ward, Christopher J and von Linde, Teresa and Conti, Alberto G and Tzeng, Sheue-Fen and Dahmani, Layla and Evans, Alexander C and Whiteside, Sarah K and Yamashita-Kanemaru, Yumi and Imianowski, Charlotte J and Yang, Jie and Gonzalez, Ignacio Moraga and Chapman, Jack and Al-Deka, Aws and Okkenhaug, Klaus and Murphy, Michael P and Swiatczak, Bartlomiej and Guittard, Geoffrey and Lugli, Enrico and Flatz, Lukas and Ho, Ping-Chih and Eil, Robert L and Roychoudhuri, Rahul},
title = {Tumor-derived antioxidants suppress immunity by depriving T cells of reactive oxygen species},
journal = {Science},
year = {2026},
doi = {10.1126/science.adz8203}
}
EUVIMED